Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Stress-related hair loss was reversed with a special medication.

A rare scalp condition with hair loss was correctly diagnosed and treated, leading to hair regrowth.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

PRP shows promise for scarring alopecia but needs more research before replacing current treatments.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Some medications can cause acne, and stopping these drugs is the main treatment.